The Joint Panel of the American Academy of Family Physicians and the American College of
Physicians, in collaboration with the Johns Hopkins Evidence-based Practice Center …

Purpose: This review summarizes the available evidence regarding the efficacy of
medications used for ventricular rate control, stroke prevention, acute conversion, and …

Atrial fibrillation is the most common arrhythmia observed in clinical practice, occurring in
0.4% of the general population and in up to 4% of people greater than 60 years old. It is …

Management strategies for the acute treatment of atrial fibrillation (AF) include:(1) the use of
intravenous drugs for rate control,(2) drug termination, or (3) direct current (DC) …

Atrial fibrillation is a supraventricular arrhythmia that adversely affects cardiac function and
increases the risk of stroke. It is the most common arrhythmia and a major source of …

BACKGROUND The AFFIRM study showed that atrial fibrillation (AF) can be treated
effectively with rate control and anticoagulation, but drug efficacy to control rate remains …

Atrial fibrillation is the most common cardiac arrhythmia. It impairs cardiac function and
increases the risk of stroke. The incidence of atrial fibrillation increases with age. Key …

Purpose: To review the efficacy and safety of electrical and pharmacologic conversion of
atrial fibrillation, strategies for maintenance of sinus rhythm, and the importance of …

When considering therapy for atrial fibrillation (AF), the dominant issues are rate control,
anticoagulation, rhythm control, and treatment of any underlying disorder. Drug choices for …

Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical
practice. Its incidence increases with age and the presence of structural heart disease. It is a …